Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -7.54 % |
3 Month Return | + 38.65 % |
1 Year Return | + 68.72 % |
Market Stats | |
Previous Close | ₹145.30 |
Open | ₹152.30 |
Volume | 17.12K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹166.89Cr |
P/E Ratio | 14.12 |
PEG Ratio | 9.41 |
Market Cap | ₹166.89 Cr |
P/B Ratio | 7.03 |
EPS | 8.38 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 6.54 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹166.89 Cr | 137.08% | 0.50 | ₹9 Cr | ₹188 Cr | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Parnax Lab Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Parnax Lab Ltd
Parnax Lab's consolidated net sales for June 2024 reached Rs 50.12 crore, up 2.83% YoY. Net profit rose 19.82% to Rs 3.98 crore, with EBITDA increasing 29.53%. The EPS improved to Rs 3.47. Shares closed at Rs 113.30, yielding 32.19% returns over six months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 1 Year
In the last 1 year, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 27.70% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.30% of holdings in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 3.98 Cr → 3.41 Cr (in ₹), with an average decrease of 14.3% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 50.23 Cr → 49.31 Cr (in ₹), with an average decrease of 1.8% per quarter
Price Dip
In the last 7 days, Parnax Lab stock has moved down by -5.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.3% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 27.7% | 0.00 | |
Others | 0% | 0.00 |
Parnax Lab Ltd in the last 5 years
Lowest (-82.38x)
May 26, 2021
Today (14.12x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (177.62x)
February 9, 2021
Parnax Lab Ltd’s net profit jumped 82.35% since last year same period to ₹3.41Cr in the Q2 2024-2025. On a quarterly growth basis, Parnax Lab Ltd has generated -14.32% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Parnax Lab Ltd is currently in a Bullish trading position according to technical analysis indicators.
Parnax Lab Ltd (506128) share price today is ₹152
Parnax Lab Ltd is not listed on NSE
Parnax Lab Ltd is listed on BSE
PE Ratio of Parnax Lab Ltd is 14.12
PE ratio = Parnax Lab Ltd Market price per share / Parnax Lab Ltd Earnings per share
Today’s traded volume of Parnax Lab Ltd(506128) is 17.12K.
Today’s market capitalisation of Parnax Lab Ltd(506128) is ₹166.89Cr.
Parnax Lab Ltd(506128 | Price |
---|---|
52 Week High | ₹193.5 |
52 Week Low | ₹80 |
Parnax Lab Ltd(506128) share price is ₹152. It is down -21.45% from its 52 Week High price of ₹193.5
Parnax Lab Ltd(506128) share price is ₹152. It is up 90.00% from its 52 Week Low price of ₹80
Parnax Lab Ltd(506128 | Returns |
---|---|
1 Day Returns | 6.7% |
1 Month Returns | -7.54% |
3 Month Returns | 38.65% |
1 Year Returns | 68.72% |